Daytime Measurements Underestimate Nocturnal Oxygen Desaturations in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

被引:40
|
作者
Hildenbrand, Florian F.
Bloch, Konrad E. [2 ]
Speich, Rudolf [3 ]
Ulrich, Silvia [1 ]
机构
[1] Univ Zurich Hosp, Resp Clin, Div Pulm, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Sleep Disorders Ctr, Dept Thorac & Cardiovasc Med, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Clin Internal Med, CH-8091 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Chronic thromboembolic pulmonary hypertension; Pulmonary arterial hypertension; Sleep disordered breathing; CHEYNE-STOKES RESPIRATION; EXERCISE PERFORMANCE; HEART-FAILURE; SLEEP; GUIDELINES; DIAGNOSIS; THERAPY; DISEASE; ADULTS;
D O I
10.1159/000341182
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Nocturnal hypoxemia is important in precapillary pulmonary hypertension (pPH) as it worsens pulmonary hemodynamics. Whether daytime oxygen saturation (SpO(2)) predicts nocturnal hypoxemia in pPH patients has not been conclusively studied. Objectives: To investigate the prevalence of nocturnal hypoxemia in comparison to daytime SpO(2) and disease severity in ambulatory patients with pulmonary hypertension. Methods: Consecutive patients diagnosed with pPH classified as either pulmonary arterial (PAH) or chronic thromboembolic pPH (CTEPH) had daytime resting and exercise SpO(2) (at the end of a 6-min walk test); thereafter, they underwent overnight pulse oximetry at home. Functional class, pro-brain natriuretic peptide (pro-BNP) and the tricuspid pressure gradient were assessed. Results: Sixty-three patients [median (quartiles) age 62 (53; 71), 43 females] with PAH (n = 44) and CTEPH (n = 19) were included. The resting SpO(2), exercise SpO(2), and mean nocturnal SpO(2) were 95% (92; 96), 88% (81; 95), and 89% (85; 92), respectively. Forty-nine patients (77%) spent >10% of the night with SpO(2) <90% (desaturators), and 33 (52%) spent >50% of the night with SpO(2) <90% (sustained desaturators). The positive predictive values of daytime SpO(2) >90% for being a nocturnal nondesaturator or sustained nondesaturator were 25 and 53%, respectively. Nocturnal SpO(2) was negatively correlated with the tricuspid pressure gradient, but not with functional class, 6-min walk test, or pro-BNP. Conclusions: Nocturnal hypoxemia is very common in PAH and CTEPH despite often normal daytime SpO(2) and reflects disease severity. Nocturnal pulse oximetry should be considered in the routine evaluation of pPH patients and research should be directed toward the treatment of nocturnal desaturation in pPH. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:477 / 484
页数:8
相关论文
共 50 条
  • [21] Predictors of physical activity in pulmonary arterial and chronic thromboembolic pulmonary hypertension
    Saxer, Stephanie
    Lichtblau, Mona
    Berlier, Charlotte
    Hasler, Elisabeth
    Schwarz, Esther
    Ulrich, Silvia
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [22] Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension
    Remy-Jardin, Martine
    Hutt, Antoine
    Remy, Jacques
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 43 (06) : 936 - 945
  • [23] Nocturnal desaturation in patients with chronic thromboembolic pulmonary hypertension.
    Taniguchi, Yu
    Fujii, Hiroyuki
    Yanaka, Kenichi
    Emoto, Noriaki
    Hirata, Kenichi
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [24] Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension
    Minai, Omar A.
    Pandya, Chirag M.
    Golish, Joseph A.
    Acecillas, Jaime F.
    McCarthy, Kevin
    Marlow, Scott
    Arroliga, Alejandro C.
    CHEST, 2007, 131 (01) : 109 - 117
  • [25] Support Experienced by Patients Living with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Ivarsson, Bodil
    Ekmehag, Bjorn
    Sjoberg, Trygve
    HEART LUNG AND CIRCULATION, 2016, 25 (01): : 35 - 40
  • [26] Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Nashat, Heba
    Da Costa, Rosa
    Barbosa, Joanna
    Harries, Carl
    Kempny, Aleksander
    Price, Laura C.
    Mc Cabe, Colm
    Gatzoulis, Michael A.
    Dimopoulos, Konstantinos
    Wort, Stephen J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] BURDEN STUDY OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION FOR COLOMBIA POPULATION
    Londono, D.
    Taborda, A.
    Chamorro, C. L.
    Rojas, K.
    VALUE IN HEALTH, 2020, 23 : S94 - S94
  • [28] Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
    Ivarsson, Bodil
    Ekmehag, Bjorn
    Sjoberg, Trygve
    NURSING RESEARCH AND PRACTICE, 2014, 2014
  • [29] Burden Study of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension for Colombia Population
    Londono, Dario
    Villaquiran, Claudio
    Duenas, Ruben
    Taborda, Alejandra
    Rojas, Kamilo
    Chamorro, Cindy
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [30] Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
    V. F. E. D. Smolders
    C. Rodríguez
    I. Blanco
    R. Szulcek
    Wim Timens
    L. Piccari
    Y. Roger
    X. Hu
    Constanza Morén
    C. Bonjoch
    L. Sebastián
    M. Castellà
    J. Osorio
    V. I. Peinado
    Harm Jan Bogaard
    P. H. A. Quax
    M. Cascante
    J. A. Barberà
    O. Tura-Ceide
    Scientific Reports, 12